Halozyme Therapeutics, Inc.
HALO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001159036
In the last 90 days, Halozyme Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 674 institutions reported holding it in 13F filings for Q2 2026, worth $9.62B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Halozyme Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 423
- +70 vs. Q3 2022
- Shares held
- 129.2M
- −2.09M (−1.6%) vs. Q3 2022
- Total value
- $7.35B
- +$2.16B (+41.5%) vs. Q3 2022
- New holders
- 90
- 111 more added
- Sold out
- 20
- 178 more reduced
4 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HALO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 674 | $9.62B |
| Q1 2026 | 637 | $7.79B |
| Q4 2025 | 619 | $8.29B |
| Q3 2025 | 604 | $8.75B |
| Q2 2025 | 552 | $6.05B |
| Q1 2025 | 550 | $7.72B |
| Q4 2024 | 509 | $5.86B |
| Q3 2024 | 510 | $7.17B |
| Q2 2024 | 460 | $6.40B |
| Q1 2024 | 413 | $5.03B |
| Q4 2023 | 411 | $4.62B |
| Q3 2023 | 390 | $4.71B |
| Q2 2023 | 370 | $4.45B |
| Q1 2023 | 387 | $4.77B |
| Q4 2022 | 423 | $7.35B |
| Q3 2022 | 357 | $5.21B |
| Q2 2022 | 368 | $5.65B |
| Q1 2022 | 316 | $5.12B |
| Q4 2021 | 326 | $5.21B |
| Q3 2021 | 326 | $5.29B |
| Q2 2021 | 315 | $5.89B |
| Q1 2021 | 337 | $5.53B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Halozyme Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tran Capital Management, L.P. | 1,084,118 | $61.7M | 7.80% | −55,052−4.8% | Reduced |
| Morgan Stanley | 1,121,894 | $63.8M | 0.01% | +257,853+29.8% | Added |
| Stephens Investment Management Group LLC | 1,294,025 | $73.7M | 1.34% | −4,909−0.4% | Reduced |
| Driehaus Capital Management LLC | 1,342,579 | $76.4M | 1.14% | −3,807−0.3% | Reduced |
| Victory Capital Management Inc | 1,415,356 | $80.5M | 0.09% | +219,670+18.4% | Added |
| Bank of New York Mellon Corp | 1,438,370 | $81.8M | 0.02% | −82,920−5.5% | Reduced |
| Dimensional Fund Advisors LP | 1,502,107 | $85.5M | 0.03% | −31,393−2.0% | Reduced |
| Charles Schwab Investment Management Inc | 1,613,006 | $91.8M | 0.03% | +2,427+0.2% | Added |
| Price T Rowe Associates Inc | 1,637,959 | $93.2M | 0.01% | +22,939+1.4% | Added |
| Goldman Sachs Group Inc | 1,993,206 | $113.4M | 0.03% | +9,265+0.5% | Added |
| Northern Trust Corp | 2,088,842 | $118.9M | 0.02% | −29,280−1.4% | Reduced |
| GW&K Investment Management, LLC | 2,088,856 | $118.9M | 1.21% | −114,186−5.2% | Reduced |
| Loomis Sayles & Co L P | 2,120,571 | $120.7M | 0.24% | −27,702−1.3% | Reduced |
| Geode Capital Management, LLC | 2,515,097 | $143.1M | 0.02% | +38,233+1.5% | Added |
| Macquarie Group Ltd | 2,605,261 | $148.2M | 0.18% | +50,294+2.0% | Added |
| JPMorgan Chase & Co | 3,227,777 | $183.7M | 0.03% | −705,249−17.9% | Reduced |
| William Blair Investment Management, LLC | 3,706,003 | $210.9M | 0.81% | −730,081−16.5% | Reduced |
| Snyder Capital Management L P | 3,983,814 | $226.7M | 5.12% | −435,114−9.8% | Reduced |
| State Street Corp | 5,714,013 | $325.1M | 0.02% | −459,365−7.4% | Reduced |
| Invesco Ltd. | 6,005,451 | $341.7M | 0.10% | +366,954+6.5% | Added |
| Artisan Partners Limited Partnership | 7,140,953 | $406.3M | 0.72% | +1,013,061+16.5% | Added |
| Vanguard Group Inc | 13,303,847 | $757.0M | 0.02% | −31,308−0.2% | Reduced |
| BlackRock Inc. | 18,215,726 | $1.04B | 0.03% | +16,093+0.1% | Added |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −271,615−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −83,937−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −74,500−100.0% | Sold out |
| APG Asset Management N.V. | 0 | $0 | 0.00% | −44,300−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −37,600−100.0% | Sold out |
| Kiwi Wealth Investments Limited Partnership | 0 | $0 | 0.00% | −18,707−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −19,100−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −6,421−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −13,061−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −10,972−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −9,969−100.0% | Sold out |
| Cim Investment Mangement Inc | 0 | $0 | 0.00% | −7,769−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,831−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −1,382−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −468−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Raffa Wealth Management, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Covington Capital Management | – | – | – | – | Not filed |
| Eaton Vance Management | – | – | – | – | Not filed |
| Corient Capital Partners, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |